ScienceDaily (Dec. 21, 2009) — Many heart transplant patients develop multiple skin cancers, with increased risk for some skin cancers among patients with other cancers and with increasing age, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals.
"Solid organ transplant recipients are at increased risk for skin cancers," the authors write as background information in the article. "Incidence, tumor burden and risk factors...
NEW YORK (Reuters Health) - People with a history of skin cancer may want to cut back on the amount of fat they eat to reduce their risk of a second skin cancer, based on study findings from Australia.
The findings link high intakes of total fat to increased risk of developing a type of skin cancer called squamous cell carcinoma among people who have a history of skin cancer.
Toll-like receptors that activate immune cells being developed as alternative cure to cancer
The Medical News
16. September 2009 05:27
The development of cancer involves the uncontrolled growth of normal cells of the body. Our immune system can sense the growth of the tumor cells and can usually eliminate them using direct killing mechanisms, mediated by natural killer cells and cytotoxic T lymphocytes. However, the tumor has an arsenal of strategies to counteract...
Potential Skin Cancer Breakthrough Tested at Scottsdale Healthcare Published Today in New England Journal of Medicine
Hedgehog trial results suggest antitumor activity in basal cell skin cancer
SCOTTSDALE, Ariz., Sept. 2 /PRNewswire-USNewswire/ -- A study published today
in the New England Journal of Medicine reports a potential new investigational
therapy for advanced and metastatic basal cell skin cancer tested at the
Virginia G. Piper Cancer Center...
LOS ANGELES, Aug 28 (Reuters) - Shares of Curis Inc rose as much as 35 percent on Friday amid renewed speculation that the company, which is developing a cancer drug with Roche Holding AG's Genentech unit, is a takeover target.
The companies are collaborating in the development of GDC-0449, which is designed to block a cell-signaling pathway called hedgehog.
The drug has been shown in small early-stage trials to shrink tumors in patients...
Blog Categories
Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
(2)
